Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
about
Chronic Granulomatous Disease; fundamental stages in our understanding of CGDX-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.Functional genomics identifies negative regulatory nodes controlling phagocyte oxidative burstInnate immunity to Aspergillus species.Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.Induction of phagocyte cytochrome b heavy chain gene expression by interferon gammaGamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils.Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitroA novel X-linked combined immunodeficiency disease.Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide.Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel diseaseTumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cellsIn vitro interferon γ improves the oxidative burst activity of neutrophils in patients with chronic granulomatous disease with a subtype of gp91phox deficiency.Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease.Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase.Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection.Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies.Relapsing Salmonella enteritidis infection in a young adult male with chronic granulomatous disease.Enhanced generation of reactive oxygen species by interferon-γ may have contributed to successful treatment of invasive pulmonary aspergillosis in a patient with chronic granulomatous disease.Immunomodulatory effects of recombinant lactoferrin during MRSA infection.Dectin-1 Activation during Leishmania amazonensis Phagocytosis Prompts Syk-Dependent Reactive Oxygen Species Production To Trigger Inflammasome Assembly and Restriction of Parasite Replication.Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing.Successful interferon-gamma therapy in a chronic granulomatous disease (CGD) patient suffering from Staphylococcus aureus hepatic abscess and invasive Candida albicans infection.The effects of inhaled interferon gamma in normal human airways.Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation.Voltage- and NADPH-dependence of electron currents generated by the phagocytic NADPH oxidase.Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease.Interferon-gamma and synthesis of surfactant components by cultured human fetal lung.Aspergillosis in Chronic Granulomatous Disease.Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.
P2860
Q21245653-220F3456-573E-4AEB-A03A-5DC220CBA650Q24538965-06A7282E-D3D0-4B17-9EE4-6B15511DF386Q28265365-C8923A3B-76B8-4F0B-8ED4-7577E5C8A013Q30434628-E2DE475A-3D97-4685-88AA-5CA81F69B6C1Q33586249-68DC1097-9D32-49A4-BB13-78E61A7E5860Q33632741-6A740CD1-2390-4F3D-82A0-22DFFFB3815DQ33637370-416AF0EA-0E51-450B-AD4F-A63D16CB0DADQ34238212-B401696C-AF45-4C77-BBF8-1F1E133066A6Q34263537-34A65A44-440D-4EBD-9285-F24A58B7D455Q34404279-6A523D37-6ABC-4B3B-9778-4ADD7385184FQ34532797-5FD3A2CF-5B09-4339-ABBC-F8EDFC4C3172Q34572421-54B5304B-2FC8-4722-AABE-B15102165A57Q35756308-3BBE2F1B-893D-4357-8487-A1982EB1A7A5Q35778617-EB3C99EB-D4ED-4174-B0EF-F7822E82E616Q37161242-2AF25DFE-3DA6-4DF1-BCC7-FB50CBF4BFBEQ37175410-78CFDA5A-6308-4822-A1E7-D879949FFDDCQ37957015-5F57DB19-1CE2-437D-865B-3FE2AC8CA5EEQ38216460-29C55397-4401-4BCF-AB6C-E7BC5730BB91Q38650890-065561B0-285E-4276-9724-391A6B269637Q39176255-BB11926E-5ADE-4353-A880-DD15E89697F8Q39486464-E20D84A5-1FAC-445F-BDA6-C037DDB29D88Q40103193-93C3EE98-17CE-4AE3-800E-2773996E51BAQ40150693-98336364-ED26-4A41-8D2A-FE19B8D4FD3BQ40722805-ABE7251A-E77D-42A2-B414-C7F940FD03A2Q41059632-9CA61BAB-F1E3-4ED8-A423-BA26FE30537FQ41809918-E2FE8266-0C68-4C69-8F96-179E15481781Q42153438-9DBA34D0-F821-4FCE-9683-1A54B60D76B7Q42584388-C6D7E1DA-590C-4FF6-9AB0-91681BBD4C03Q46129462-D472D0EB-0C83-48C5-944B-85BAACC76CC1Q47645142-94142DDF-4C24-4991-B416-E608C9193BDBQ54973296-A5A22781-A42E-440D-BC81-45A205F032E2
P2860
Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Recombinant interferon gamma a ...... chronic granulomatous disease.
@ast
Recombinant interferon gamma a ...... chronic granulomatous disease.
@en
type
label
Recombinant interferon gamma a ...... chronic granulomatous disease.
@ast
Recombinant interferon gamma a ...... chronic granulomatous disease.
@en
prefLabel
Recombinant interferon gamma a ...... chronic granulomatous disease.
@ast
Recombinant interferon gamma a ...... chronic granulomatous disease.
@en
P2093
P2860
P356
P1476
Recombinant interferon gamma a ...... chronic granulomatous disease.
@en
P2093
P E Newburger
R A Ezekowitz
P2860
P304
P356
10.1172/JCI113153
P407
P577
1987-10-01T00:00:00Z